股本结构
单位：万股
| 公告日期 | 2025-10-06 | 2025-08-06 | 2025-06-25 | 2025-05-01 | 2025-05-01 | 2025-06-25 |
|---|---|---|---|---|---|---|
| 证券总股本 | 187.21 | 186.72 | 71.32 | 58.33 | 464.86 | 56.80 |
| 普通股本 | 187.21 | 186.72 | 71.32 | 58.33 | 464.86 | 56.80 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-09-26 | 2025-07-31 | 2025-06-19 | 2025-05-05 | 2025-05-01 | 2025-03-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-10-06 | 187.21 | 未披露 | 定期报告 | 2025-09-26 |
| 2025-08-06 | 186.72 | 未披露 | 定期报告 | 2025-07-31 |
| 2025-06-25 | 71.32 | 未披露 | 定期报告 | 2025-06-19 |
| 2025-05-01 | 58.33 | 未披露 |
更多>>
a 1-for-7.97 consolidation ratio of common share
|
2025-05-05 |
| 2025-05-01 | 464.86 | 未披露 | 定期报告 | 2025-05-01 |
| 2025-06-25 | 56.80 | 未披露 |
更多>>
From March 31, 2024 to March 31, 2025
Issuance of shares to third party advisors
Issuance of shares for convertible note
Issuance of shares for ELOC, net of issuance costs
Issuance of shares for warrant exchange
Issuance of shares for promissory notes
Issuance of shares for Psyence Labs Ltd shares
Issuance of units for PIPE financing, net of issuance costs
Issuance of shares for warrant conversion
|
2025-03-31 |
| 2025-03-04 | 452.71 | 未披露 | 定期报告 | 2025-02-28 |
| 2025-01-24 | 390.71 | 未披露 | 定期报告 | 2025-01-22 |
| 2025-01-24 | 352.71 | 未披露 | 定期报告 | 2025-01-10 |
| 2024-12-20 | 342.71 | 未披露 | 定期报告 | 2024-12-17 |
| 2024-11-19 | 84.51 | 未披露 |
更多>>
a consolidation of the Company’s common shares at a ratio of up to 1 common share for every 75 common shares held
|
2024-11-26 |
| 2024-10-30 | 6337.96 | 未披露 | 定期报告 | 2024-10-30 |
| 2024-10-23 | 5433.42 | 未披露 | 定期报告 | 2024-10-23 |
| 2024-11-12 | 5033.42 | 未披露 | 定期报告 | 2024-10-10 |
| 2024-10-02 | 4012.72 | 未披露 | 定期报告 | 2024-09-30 |
| 2024-08-19 | 1669.66 | 未披露 | 定期报告 | 2024-08-13 |
| 2024-07-29 | 1652.45 | 未披露 | 定期报告 | 2024-07-29 |
| 2024-01-31 | 1339.07 | 未披露 | 定期报告 | 2024-01-26 |
| 2023-11-21 | 878.80 | 未披露 | 定期报告 | 2023-09-30 |
| 2023-08-22 | 878.80 | 未披露 | 定期报告 | 2023-08-14 |
| 2023-05-15 | 917.75 | 未披露 | 定期报告 | 2023-03-31 |
| 2023-09-20 | 917.75 | 未披露 | 定期报告 | 2023-03-20 |
| 2022-04-01 | 3267.50 | 未披露 |
更多>>
From February 25, 2021 to December 31, 2021
Issuance of Ordinary Shares to Initial Shareholders
Sale of Private Placement units
Forfeiture of issued shares of Initial Shareholders
|
2021-12-31 |
| 2021-12-03 | 3267.50 | 未披露 | 定期报告 | 2021-12-10 |
a 1-for-7.97 consolidation ratio of common share
From March 31, 2024 to March 31, 2025
Issuance of shares to third party advisors
Issuance of shares for convertible note
Issuance of shares for ELOC, net of issuance costs
Issuance of shares for warrant exchange
Issuance of shares for promissory notes
Issuance of shares for Psyence Labs Ltd shares
Issuance of units for PIPE financing, net of issuance costs
Issuance of shares for warrant conversion
a consolidation of the Company’s common shares at a ratio of up to 1 common share for every 75 common shares held
From February 25, 2021 to December 31, 2021
Issuance of Ordinary Shares to Initial Shareholders
Sale of Private Placement units
Forfeiture of issued shares of Initial Shareholders